Rare diseases
Investigational molecules
Locations
Back to Germany1 132 clinical trials in Heidelberg, Germany across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis
GermanyStudy on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer
GermanyStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
GermanyStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
GermanyStudy on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors
GermanyStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
GermanyStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
GermanyStudy of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer
GermanyStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
GermanyStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
GermanyStudy of Entrectinib in Children and Adolescents with Advanced or Metastatic Solid Tumors or Primary CNS Tumors with No Satisfactory Treatment Options
GermanyStudy on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of TTR amyloidosis cardiovascular complications. Studies evaluating new therapeutic approaches for pulmonary hypertension.
Research includes evaluation of novel compounds for heart conditions and preventive therapies.
Comprehensive research in lung cancer, bladder cancer, and melanoma treatments. Advanced trials for various lymphomas and leukemias using innovative therapeutic approaches.
Focus on targeted therapies and immunological approaches in cancer treatment.
Groundbreaking research in kidney transplantation with innovative immune system modification approaches. Studies exploring new methods to improve transplant outcomes.
Emphasis on developing personalized immunosuppression strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
